Population pharmacokinetics and significant under-dosing of anti-tuberculosis medications in people with HIV and Critical Illness.
Critical illness from tuberculosis (TB) bloodstream infection results in a high case fatality rate for people living with human immunodeficiency virus (HIV). Critical illness can lead to altered pharmacokinetics and suboptimal drug exposures.